APPLIED DNA SCIENCES INC - COM NEW (APDN)

CUSIP: 03815U201

Q2 2019 13F Holders as of 30 Jun 2019

Type / Class
Equity / COM NEW
Total 13F shares
2,172,532
Share change
-41,143
Total reported value
$1,085,283
Price per share
$0.50
Number of holders
20
Value change
-$47,813
Number of buys
2
Number of sells
6

Quarterly Holders Quick Answers

What is CUSIP 03815U201?
CUSIP 03815U201 identifies APDN - APPLIED DNA SCIENCES INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of APPLIED DNA SCIENCES INC - COM NEW (APDN) as of Q2 2019

As of 30 Jun 2019, APPLIED DNA SCIENCES INC - COM NEW (APDN) was held by 20 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,172,532 shares. The largest 10 holders included VANGUARD GROUP INC, CHASE INVESTMENT COUNSEL CORP, GEODE CAPITAL MANAGEMENT, LLC, Creative Planning, BlackRock Inc., WELLS FARGO & COMPANY/MN, MORGAN STANLEY, BREWIN DOLPHIN LTD, Capital Investment Advisors, LLC, and REILLY FINANCIAL ADVISORS, LLC. This page lists 20 institutional shareholders reporting positions in this security for the Q2 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.